WALTHAM, MA -PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announceda free demonstration version of its universal 3D image analysis Volocity® software. This new shareware is designed to give research institutions working with confocal microscopesa deeper understanding of cellular biology. Analyzing images in 3D delivers more accurate measurements and the quantitative datato advance scientific breakthroughs in cellular sciences, including cancer and stem cell research and neurological and infectious diseases.
Volocity Demo is a fully functional analysis version of the software that allows researchers to take their own microscope image data, and explore and evaluate Volocity's analysis capabilities on their own time without time limitations. It is supported by an online "getting started” guide, and a library of video and text tutorials explaining how to use the key features of the software. This free downloadable versionallows scientists to measure and analyze the crucial relationships between tissues, cells or their organelles, generate quantitative data and create 3D images and movies which they can then go on to publish with a full Volocity license.
The Volocity® software platformis a portfolio of high performance 3D image analysis products for the visualization and measurement of cells. It is a universal solution for 3D analysis of fluorescence microscopy images that enables researchers to relate cellular structure to function. Over 1,000 research groups have already published their results using PerkinElmer image analysis software.
For more information and to download the free trial of Volocity Demo, please visit, www.perkinelmer.com/imaging.
About PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of approximately$1.8 billion in 2009 has around 8,800 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.
Phone: (781) 663-5871